RPB researchers have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver. In 459 patients with ocular melanoma at 12 centers in the United States and Canada, the researchers found the test could successfully classify tumors more than 97 percent of the time.
Nearly half of patients with ocular melanoma have the type that will spread, and of those patients it is fatal nearly 90 percent of the time.
July 25, 2012
|General Info||Research Scientists & Grantees||Eye Care Specialists||Donors & Partners|